Navigation Links
IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729
Date:3/12/2009

Test builds on company's suite of tests to evaluate immune function

LENEXA, Kan., March 12 /PRNewswire/ -- IBT Laboratories, a leading clinical-diagnostics and biomedical-research laboratory specializing in immunology and allergy assays, will launch a new diagnostic assay designed to help physicians better understand and manage their patients who have recurrent infections. The company will introduce the Pneumococcal Antibody Avidity Test at the annual meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI), which opens tomorrow in Washington, DC. The exhibition runs Saturday, March 14 through Monday, March 16, 2009.

According to IBT President, Maureen Loftus, the test builds on the company's suite of assays evaluating immune function. "IBT Laboratories was one of the first laboratories to develop a commercial pneumococcal assay to measure the concentration of antibodies produced in response to the pneumococcal vaccines - today, one of the most-widely prescribed tests used to determine why a patient has recurrent infections. Our new Avidity test now lets the clinician assess the effectiveness of those antibodies. Together, these pneumococcal tests provide more insight into the strengths and weaknesses of a patient's immune system."

IBT offers the widest range of allergy and immunology tests of any laboratory worldwide. The company has an expanded scientific team dedicated specifically to assay development. Its pipeline of new tests slated for launch during 2009 includes traditional and molecular assays based on the latest findings in allergy/immunology research.

Other new tests that the company will feature at AAAAI include the ProGenotyper(TM) Filaggrin Mutation Detection Test, the latest in IBT's expanding menu of molecular assays, and the T-Cell Rx(TM) assay, which adds to IBT's expansive line of tests for adverse drug reactions.
'/>"/>

SOURCE IBT Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
3. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
4. Romark Laboratories Raises $18 Million in Institutional Financing
5. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
6. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
7. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
10. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
11. Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... ROCKVILLE, Md. , March 26, 2015  RegeneRx ... that it has received a patent acceptance notice from ... beta 4 (TB4) to prevent or reduce tissue damage ... often the case when cardiac vessels are opened after ... circumstances when treating stroke victims. Damage can ...
(Date:3/26/2015)... HEIGHTS, Mich. , March 26, 2015 InfuSystem ... infusion pumps and related services for the healthcare industry in ... Canada , announced today it has secured a new ... has retired its previous $36.5 million credit facility with its ... the Company entered into the new five-year senior secured credit ...
(Date:3/26/2015)... TAMPA, Fla. , March 26, 2015 ... owned subsidiary of Oxis International, Inc. [OTC: ... the execution of an exclusive option agreement ... certain patents/intellectual properties developed by Dr. ... Innovation and Professor, Pharmaceutical Sciences, School of ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3
... /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH ) ... marketer of orthopedic implants in China, today announced that the ... August 16, 2011, before the market opens. Kanghui ... August 16, 2011 to discuss second quarter results and answer ...
... ATLANTA, July 28, 2011 Data presented this week at ... many people have low vitamin D levels and that testing ... to published data from the Third National Health and Nutrition ... only 23 percent of Americans have vitamin D levels over ...
Cached Medicine Technology:China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 2Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels 3
(Date:3/27/2015)... Trail mix is the perfect, healthy snack for families on ... the game! It’s portable, lightweight and provides a wide range ... new line of specialty trail mixes that satisfy your hunger ... with nutritious, 100% all natural ingredients. , These tasty combinations ... and fiber to your diet and boost energy. The mixes ...
(Date:3/27/2015)... Lakes, New Jersey (PRWEB) March 27, 2015 ... teenage singer-songwriter-actress has released the official music video for ... Entertainment label. , Combining live-action and abstract styling ... already can be viewed on YouTube, Vimeo, and assorted ... popularize in the development of an expanding full-scale marketing ...
(Date:3/27/2015)... Yisrayl Hawkins, Pastor and Overseer at The House ... live in Peace is through the Laws of Peace written ... week. , The article titled, “Yahweh’s Way-The Great Difference” focuses ... straying away from the original biblical instructions has caused mass ... has been created in the world is based on man-made ...
(Date:3/26/2015)... 2015 Elfster.com, the top-rated Secret Santa ... bucket list generator capabilities to its leading Secret Santa ... a list that one creates of things to do ... of the same name. Nowadays many millennials are ... their summer achievements. , "We are greatly expanding our ...
(Date:3/26/2015)... 2015 UC Davis will establish a ... origins of schizophrenia: A Silvio O. Conte Center for ... such centers in the United States. , The center ... the National Institutes of Mental Health, which will allow ... that an origin of schizophrenia may be dysregulation of ...
Breaking Medicine News(10 mins):Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2Health News:Plans for Bucket List Generator - Just In Time for Summer - Announced by Elfster 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4
... Dr. Lee ... the U.S. to practice health care in a free-market economy. In speaking engagements and in ... the fragility of such a system and its threat to real health care! , ... (PRWEB) December 14, 2009 -- ...
... , COLUMBUS, Ohio, Dec. 14 ... in operations and services in order to deal with a 92 ... from $6.25 to $12.01 per bed per day, scheduled for December ... an additional $17,520 to the state each month, or $210,240 per ...
... , , SANTA ANA, Calif., Dec. 14 Grubb ... of directors has authorized a daily distribution to stockholders of record ... period commencing on Jan. 1, 2010 and ending on Feb. 28, ... in the calendar year and will be equal to an annualized ...
... , BOSTON, Dec. ... giving the Apollo crew instructions for landing on the moon, ... anything.,Years later, Kurth realized there was one thing that science ... though dialysis machines,would keep her alive for awhile, she would ...
... small and shouldn,t worry most users, researcher says , ... take antidepressants may have a small but statistically significant ... not on the medications, a new study finds. , ... stressed Dr. Jordan W. Smoller, an associate professor of ...
... obesity are linked to an increased risk of certain cancers. ... insulin preparation marketed under the trade name Lantus), may be ... insulins or oral glucose lowering medications. However, these studies ... that may have driven the association. On the ...
Cached Medicine News:Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
...
...
... The Maxim Knee employs titanium alloy ... an excellent fixation surface. Biomet's ArCom ... durable and proven bearing material. The ... full inter-changeability. Modular tibial components offer ...
... the knee and hip. MOST Options is ... knee and hip that provides the surgeon ... implant selection, connection choice and fixation to ... addresses the needs of patients with minimal ...
Medicine Products: